Stem Cells Translational Medicine

Aims & Scope

STEM CELLS Translational Medicine is a monthly, peer-reviewed, largely online, open access journal.

STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy.

By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes.

The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells, including their characterization and manipulation, and the translation of their clinical aspects of from the bench to patient care.

STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,822.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mesenchymal Stem Cells: Time to Change the Name!

  Citation: 886

  Authors: Arnold I.

• Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression

  Citation: 653

  Authors: Thorsten R., Josephine, André, Jana, Anna-Kristin, Stefan, Kyra, Peter A., Bernd, Dirk M.

• Concise Review: Role of Mesenchymal Stem Cells in Wound Repair

  Citation: 641

  Authors: Scott, Erasmo A., Dana, Alla, Michelle A.

• Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine

  Citation: 597

  Authors: Rebekah M., Michael, Victor, James H., Andre J., Simon M.

• Bioprinted Amniotic Fluid-Derived Stem Cells Accelerate Healing of Large Skin Wounds

  Citation: 574

  Authors: Aleksander, David, Edi, Anthony, John D., James, Shay

• Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target

  Citation: 520

  Authors: Yongmin, Xiangsheng, Daoyan

• Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing

  Citation: 494

  Authors: Shuo, Chen, Yuntong, Chunyu, Chao, Hongda, Xijing, Minjuan, Kaihong, Yunpeng, Yue, Houqi, Xin

• Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization

  Citation: 461

  Authors: Claudia, Daniele, Carolina, Valentina, Elisa, Luisa, Pamela, Maria Carla, Luigi, Chiara, Michela, Ranieri, Roberta

• Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial

  Citation: 413

  Authors: Yves-Marie, Lars, Rosanna, Oliver, Christophe, Frank, Luc, Louis, Sandrine, Philippe, Danièle, François, Catherine, Gina, Joachim, Daniel, Sophie, Ulrich, Christian

• Human Umbilical Cord Mesenchymal Stem Cell Exosomes Enhance Angiogenesis Through the Wnt4/β-Catenin Pathway

  Citation: 395

  Authors: Bin, Xiaodan, Xu, Yaoxiang, Yongmin, Hui, Yanhua, Lijun, Zhaoji, Wei, Hui, Wenrong